The United States Food and Drug Administration (FDA) announced a recall of reworked Philips Respironics machines due to silicone foam deterioration that, if inhaled, could cause serious illness, injury and even death.
The February 2023 recall, classified as most serious by the FDA, follows nearly two years of the health care equipment manufacturer under inspection and scrutiny.
The recall applies to Philips Trilogy 100®, Trilogy 200® and Garbin Plus® models distributed between March and September 2022 — covering a total of 13,811 machines.
These machines use a special foam, known as PE-PUR foam, to reduce sound. However, this foam can
Continue Reading What to Know About the February 2023 Updates to Philips CPAP Recall